Summary:
EDUCATION
Ph.D. (January **** - June 2013)
St. John's University, Queens, New York
Major: Pharmacology (Cancer pharmacology and biology)
Cumulative GPA: 3.72/4.0
Master of Science, (September 2007 - December 2009)
St. John's University, Jamaica, New York
Major: Pharmacology
Cumulative GPA: 3.65/4.0
Bachelor of Science, (2002- 2006)
K.B. Institute of Pharmaceutical Education and research, India
Major: Pharmacy
Cumulative GPA: 3.9/4.0
ACADEMIC APPOINTMENTS
POST DOCTORAL FELLOW (Neurooncology and cell biology Lab) (07/2013-
CURRENT)
The Feinstein Institute for Medical research, North Shore LIJ
Delineate the role of microglia in glioblastoma growth and invasion. To
develop a drug that inhibits the microglial assistance in the glioblastoma
growth and invasion.
To find out the role of tumor microenvironment in the triple negative
breast cancer metastasis (the most aggressive form of the breast cancer)
To develop a high throughput assay for the glioblastoma stem cells
inhibitor identification.
College Of Pharmacy and Health Sciences, St. John's University, Queens, New
York 11439
TEACHING FELLOW (08/2011-05/2013)
> Taught molecular biology laboratory courses including pharmacology,
biochemistry, oncology, immunology, endocrinology, chemistry,
bacterial transformation and translation laboratory courses to
graduate pharmacy students (2nd- 5th year).
> Responsibly and effectively managed class and lab with a team of 3
assistants and implemented strategic plans into practice.
> Supervised high school, Pharm D, Master students and visiting scholar
at ZS Chen's lab, St John's University, NY.
Teaching Assistant (01/2009-07/2011)
> Teaching assistant since Spring'09, responsible for teaching and
conducting laboratory for Pharmacy undergraduate students
> Supervise students and provide instruction in Biomed-I and
Pharmaceutical Toxicology.
INDUSTRIAL APPOINTMENTS
> Quality control chemist (A&Z pharmaceutical Inc. NY) May 2009-August
2009
> Performed quality control analysis of finished, stability and
validation samples. Involved in validation and calibration of QC
laboratory equipment.
> Worked in a fast-paced environment. Familiar with GLP regulations.
ACHIEVEMENTS AND AWARDS
. Student of the year (2012) in Chen's cancer pharmacology lab for
outstanding research performance.
. 4th hottest article in Science Direct from April - Sept 2009. "Tiwari
AK and Sodani K et al (2009). Nilotinib (AMN107, Tasigna) reverses
multidrug resistance by inhibiting the activity of the ABCB1/Pgp and
ABCG2/BCRP/MXR transporters. Biochem Pharmacol"
http://top25.sciencedirect.com/subject/pharmacology-toxicology-and-
pharmaceutical-science/20/journal/biochemical
pharmacology/00062952/archive/22/
. Full scholarship with tuition waiver and stipend from St. John's
University for both M.S. and PhD - 2009 to 2013
. One of the top 20 students of Gujarat University in Pharmacy Major.
. Secured 163rd Rank in the National level exam for graduates known as
GATE'06 organized by Indian Institute of Technology, Kharagpur and
Ministry of HRD.
PROFESSIONAL AFFILIATION:
> American Association for Cancer Research (AACR) - since 2009.
> American Association for the Advancement of Science (AAAS) - since
2010
> New york academy of sciences (NYAS) - since 2012
JOURNAL REFREE
> Pharmaceutica Analytica Acta (PAA)
> J. Cancer Research Updates (JCRU)
> J. of Animal Production Advances (JAPA)
> Bioinorganic Chemistry and Applications
> Pakistan journal of Pharmaceutical Sciences (PJPS)
Editorial Board Member
> Int. J. of Toxicological and Pharmacological Res. (IJTPR)
> Vedid Research International Cell Signaling (VRI-CS)
> Translational Clinical Biology
TECHNICAL SKILLS
Pharmacology: Microglial and mammalian (cancer and normal) cell
culture, Generating and characterizing drug resistant cell lines, High
Throughput Screening (HTS) using cell viability assays i.e. colony
formation, MTT/MTS/XTT/Trypan blue assays, Inside-out membrane vesicle
preparations by Nitrogen Cavitation Methods (NCM), monolayer trans-
well transport assay, Cellular-based transport assay including rapid
filtration methods, transporter kinetics, Drug accumulation, efflux
and uptake assays, membrane permeability assays.
Whole Animal pharmacokinetics; dosing iv, ip, sc, po,; Blood
collection - Orbital sinus venipuncture; nude mice xenograft models
Stereotactic orthotopic intracranial brain cancer tumor model
Molecular biology and Biochemistry: Invasion assay, Cytokine array,
Cellular fractionation including Protein, DNA and RNA - isolation and
detection, Cell-line stabilization through Transient/Stable
transfection and electroporation techniques, Protein/RNA/DNA
purification and quantification, Plasmid restriction digest, Western
Blots, Gel preparation, ATPase assay, ELISA, Immunocytochemistry,
Enzyme activity, Kinetic assays, Chromatography, Electrophoresis of
DNA.
> Analytical: HPLC and UPLC based assay; UV, IR, Dissolution,
Disintegration, Karl fisher instrument handling.
Microbiology: Aseptic techniques, Bacterial cell culture, Bacterial
transformation, Microscopy, Kirby-Bauer antibiotic sensitivity test,
Characterizing microbial resistance and sensitivity, Gram staining.
Computers: PC operation and Microsoft office applications, database
and analytical software such as Sigma Plot, Prism5, ImageJ.
PUBLICATIONS
Published work:
. Kamlesh Sodani, Amit K. Tiwari, Satyakam Singh, Atish Patel, Zhi-Jie
Xiao, Jun-Jiang Chen, Yue-Li Sun, Tanaji T. Talele, Zhe-Sheng Chen
"GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2-
and ABCB1-mediated drug resistance." Biochem Pharmacol. 2012 Jun
15;83(12):1613-22.
. Kamlesh Sodani, Atish Patel, Rishil J Kathawala and Zhe-Sheng Chen
"Multidrug resistance associated proteins (MRPs) in multidrug
resistance." Chin J Cancer. 2012 Feb;31(2):58-72
. Amit K. Tiwari, Kamlesh Sodani, Chun-ling Dai, Satyakam Singh, Alaa H.
Abuznait, Zhi-Jie Xiao, Saurabh Vispute, Atish Patel, Tanaji T.
Talele, Amal Kaddoumi, James M. Gallo, Zhe-Sheng Chen "Nilotinib
potentiates anticancer sensitivity in murine multidrug resistance
xenograft models" Cancer Lett. 2012 Oct 9.
. Atish Patel, Amit K. Tiwari, Satyakam Singh, Kamlesh Sodani, Nagaraju
Anreddy, Tanaji T. Talele, Ralph Stephani, Suresh V. Ambudkar, Zhe-
Sheng Chen "PD173074, a selective FGFR inhibitor, reverses ABCB1
mediated drug resistance in cancer cells" Cancer Chemother Pharmacol.
2013 May 15
. Amit Kumar Tiwari, Kamlesh Sodani, Sirong Wang, Ye-Hong Kuang, Charles
R. Ashby Jr., Xiang Chen, Zhe-Sheng Chen "Nilotinib (AMN107, Tasigna)
reverses multidrug resistance by inhibiting the activity of the
ABCB1/Pgpand ABCG2/BCRP/MXR transporters" Biochem Pharmacol. 2009 Jul
15;78(2):153-6
. Yue-Li Sun, Jun-Jiang Chen, Priyank Kumar, Kang Chen, Kamlesh Sodani,
Atish Patel, Yang-Lu Chen, Si-Dong Chen, Wen-Qi Jiang and Zhe-Sheng
Chen "Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by
Tariquidar" Accepted in Plos One.
. Dong-Mei Zhang, Chang Shu, Jun-Jiang Chen, Kamlesh Sodani, Jiao Wang,
Jaya Bhatnagar, Ping Lan, Zhi-Xiong Ruan, Zhijie Xiao, Suresh V.
Ambudkar, Wei-Min Chen, Zhe-Sheng Chen, Wen-Cai Ye "BBA, A novel 23-
hydroxybetulinic acid derivative, potently reverses ABCB1-mediated
drug resistance in vitro and in vivo" Mol Pharm. 2012 Nov 5;9(11):3147-
59.
. Jun-Jiang Chen, Yue-Li Sun, Amit K Tiwari, Zhi-Jie Xiao, Kamlesh
Sodani, Dong-Hua Yang, Wen-Qi Jiang, Si-Dong Chen, Zhe-Sheng Chen,
"PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug
resistance by inhibiting the efflux function of multidrug resistance
protein 7 (ATP-binding Cassette C10) transporter." Cancer Sci. 2012
Aug;103(8):1531-7.
. Ye-Hong Kuang, Jay P. Patel, Kamlesh Sodani, Chun-Pu Wu, Li-Qiu Liao,
Amit K. Tiwari, Chun-Ling Dai, Xiang Chen, Li-Wu Fu, Suresh V.
Ambudkar, Vijaya L. Korlipara, Zhe-Sheng Chen "OSI-930 ANALOGUES AS
POTENT ABCG2-MEDIATED MULTIDRUG RESISTANCE REVERSAL AGENTS" Biochem
Pharmacol. 2012 Sep 15;84(6):766-74.
. Ke-jun Liu, Xiaodong Su, Jing-Dun Xie, Xinggui Chen, Fang Wang, Yong-
ju Liang, Satyakam Singh, Tanaji T. Talele, Kamlesh Sodani, Zhe-Sheng
Chen,, Hai-Ying Wu and Li-wu Fu "AZD0530 (saracatinib) Reverses ABCB1-
mediated Multidrug Resistance in Cancer Cells by Inhibiting its
Transport Function" Int J Cancer. 2013 Jan 1;132(1):224-35.
. Tianwen Li,Yongchong Yang, Changmei Cheng, Amit K. Tiwari, Kamlesh
Sodani, Yufen Zhao, Ioana Abraham, and Zhe-Sheng Chen "Design,
synthesis and biological evaluation of N-arylphenyl-2,2-
dichloroacetamide analogues as a anti-cancer agents" Bioorg Med Chem
Lett. 2012 Dec 1;22(23):7268-71
Tiwari AK, Sodani K, Dai CL, Ashby CR Jr, Chen ZS "Revisiting the ABCs
of multidrug resistance in cancer chemotherapy." Curr Pharm
Biotechnol. 2011 Apr;12(4):570-94
. Ye-hong Kuang, Tong Shen, Xiang Chen, Kamlesh Sodani, Elizabeth
Hopper-Borge, Amit K Tiwari, Kevin Jeferson Lee, Zhe-Sheng Chen
"Lapatinib and erlotinib are potent reversal agents for MRP7(ABCC10)-
mediated multidrug resistance" Biochem Pharmacol. 2010 Jan
15;79(2):154-61.
. Amit Kumar Tiwari, Kamlesh Sodani, Zhe-Sheng Chen "Current advances in
modulation of ABC transporter mediated multidrug resistance in
cancer." International Journal of Toxicological and Pharmacological
Research 2009, Volume 1, Issue 1 Page 1 - 6.
. Jun-Jiang Chen, Atish patel, Kamlesh Sodani, Amit tiwari, Jiao Wang,
Zhijie Xiao, Wei-Min Chen, Zhe-Sheng Chen, Wen-Cai Ye "BBA, A novel 23-
hydroxybetulinic acid derivative reverses ABCC10-mediated drug
resistance in vitro" (accepted in Plos One)
Manuscript in progress:
. Kamlesh Sodani, Atish Patel, Satyakam singh, Nagaraju anreddy Zhe-
sheng Chen " Telatinib antagonizes ABCG2-mediated drug resistance"
(Submitted to Cancer letters).
. Kamlesh Sodani, Amit K. Tiwari, Chun-ling Dai, Alaa H. Abuznait,
Zhi-Jie Xiao, Atish Patel, Amal Kaddoumi, Charles Ashby Jr., Zhe-Sheng
Chen "Sildenafil potentiates the anticancer activity of paclitaxel in
ABCB1-mediated multidrug resistance xenograft mode" (submitted to
cancer chemotherapy and pharmacology)
. Rishil J Kathawala, Yue-Li Sun, Jun-Jiang Chen, Chun-Ling Dai,
Kang Chen, Kamlesh Sodani, Atish Patel, Charles R. Ashby Jr., Zhe-
Sheng Chen "Attenuation of ABCC10- and ABCG2- mediated multi-drug
resistance by masitinib (AB1010)" (Manuscript in preparation)
. Hui Zhang, Yun-Kai Zhang, Rishil J. Kathawala, Atish Patel, Kamlesh
Sodani, Tanaji T. Talele, Zhe-Sheng Chen, Li-Wu Fu "WHI-P154 Enhances
the Efficacy of ABCG2-substrate Chemotherapeutic Agents in ABCG2
Overexpressing Cells" (submitted to Journal of Translational Medicine)
PRESENTATION
Poster
. Kamlesh Sodani, Amit K. Tiwari, Chun-ling Dai, Alaa H. Abuznait, Zhi-
Jie Xiao, Atish Patel, Amal Kaddoumi, Charles Ashby Jr., Zhe-Sheng
Chen "Sildenafil potentiates the anticancer activity of paclitaxel in
ABCB1-mediated multidrug resistance xenograft mode" 104th American
Association for Cancer Research (AACR) 2013, Washington DC
. Kamlesh Sodani, Atish Patel, Amit K. Tiwari, Satyakam Singh, Nagaraju
Anreddy, Tanaji T. Talele, Ralph Stephani, Suresh V. Ambudkar, Zhe-
Sheng Chen "PD173074, a selective FGFR inhibitor, reverses ABCB1
mediated drug resistance in cancer cells" Gorden Research Conference:
Multi-Drug Efflux Systems, Ventura, CA
. Kamlesh Sodani, Amit K. Tiwari, Satyakam Singh, Atish Patel, Zhi-Jie
Xiao, Jun-Jiang Chen, Yue-Li Sun, Tanaji T. Talele, Zhe-Sheng Chen
"GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2-
and ABCB1-mediated drug resistance." 103rd American Association for
Cancer Research (AACR) 2012, Chicago IL
. Sodani K, Kuang YH, Shen T, Vispute S. Tiwari AK, Lei Y. Lee JW, Chen
X, Fu LW and Chen ZS Lapatinib, erlotinib, imatinib and nilotinib are
potent reversal agents for MRP7 (ABCC10)- mediated multidrug
resistance. 101st American Association for Cancer Research (AACR),
Washington, DC, USA April 17-22, 2010
Tiwari AK, Sodani K, Wang S, Kuang YH, Chen X, Chen K, Ashby CR, Chen
ZS. Nilotinib (AMN107, Tasigna) reverses multidrug resistance by
inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR
transporters. 101st American Association for Cancer Research (AACR),
Washington, DC, USA April 17-22, 2010
. Kamlesh sodani, "A Novel Dual c-Kit and KDR Tyrosine Kinase Inhibitor
And Its Analogues Reverses ABCG2- mediated Multi-drug Resistance" 7th
Annual North American ABC meeting. Maryland.
. Tiwari AK, Sodani K, Wang S, Kuang YH, Chen X, Chen K, Ashby CR, Chen
ZS. Nilotinib (AMN107, Tasigna) reverses multidrug resistance by
inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR
transporters. 6th North American ABC workshop. NCI, NIH, Bethesda, MD
20892; September 24-25, 2009
. Sodani K, Tiwari AK, Kuang YH, Shen T, D'Ambra TM, Lei Y, Lee J, Chen
X, Ashby CR, Chen ZS. Lapatinib, erlotinib, imatinib and nilotinib are
potent reversal agents for MRP7 (ABCC10)-mediated multidrug
resistance. 6th North American ABC workshop. NCI, NIH, Bethesda, MD
20892; September 24-25, 2009.
. Chen ZS, Tiwari AK, Shi Z, Dai CL, Shukla S, Wu CP, Wang SR, Abraham
I, Sodani K, Ashby CR, Kuang YH, Robey RW, Fu LW, Bates SE, Ambudkar
SV. Tyrosine kinase inhibitors as modulators of multidrug resistance
in cancer. Multidrug Resistance & ABC Transporters Conference.
Baltimore, Maryland USA, November 5th, 2009
. Tiwari AK, Sodani K, Wang S, Kuang YH, Chen X, Chen K, Ashby CR, Chen
ZS. Nilotinib (AMN107, Tasigna) reverses multidrug resistance by
inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR
transporters. St. John's University, Queens NY-11366 April 2009
Podium talk
. Kamlesh sodani, "Nilotinib potentiates anticancer sensitivity in
murine multidrug resistance xenograft models" 9th Annual North
American ABC meeting. Maryland
. Kamlesh sodani, "A Novel Dual c-Kit and KDR Tyrosine Kinase Inhibitor
And Its Analogues Reverses ABCG2- mediated Multi-drug Resistance" 7th
Annual North American ABC meeting. Maryland
. Kamlesh sodani, "Lapatinib, erlotinib, imatinib and nilotinib are
potent reversal agents for MRP7 (ABCC10)-mediated multidrug
resistance." 6th Annual North American ABC meeting. Maryland
REFERENCES
Available upon request